Table 5.
Annual number of HPV 6/11/16/18 events prevented by quadrivalent HPV vaccination of 12 to 17 year old girls in Germany and screening, compared with screening alone
| |
Annual number of disease events prevented |
||||
|---|---|---|---|---|---|
|
Time since start of vaccination programme (years) | |||||
| 5 | 15 | 25 | 50 | 100 | |
| Cervical cancer |
5 |
298 |
953 |
2,474 |
2,955 |
| Cervical cancer deaths |
0 |
21 |
135 |
559 |
720 |
| CIN 2/3 |
1,711 |
9,288 |
12,694 |
14,899 |
15,429 |
| CIN 1 |
899 |
3,552 |
4,366 |
4,751 |
4,829 |
| Genital warts | |||||
| female |
16,350 |
30,780 |
33,001 |
35,075 |
36,049 |
| male |
13,874 |
26,999 |
27,172 |
25,948 |
25,691 |
| Total |
30,225 |
57,779 |
60,173 |
61,023 |
61,740 |
| HPV 16/18 events |
2,322 |
12,134 |
16,876 |
20,906 |
21,966 |
| HPV 6/11 events | 30,518 | 58,783 | 61,309 | 62,241 | 62,987 |